Evaluating Lu-177-radiolabelled antibodies for TNBC theranostics

23/09/2024

SPECT images captured by the γ-CUBE showing 177Lu accumulation in tumours in a subcutaneous TROP-2 positive TNBC xenograft mice model.

At a glance

> In a recent study, the MOLECUBES γ-CUBE has been used to image antibodies radiolabelled with 177Lu to evaluate its effectiveness in treating triple-negative breast cancer (TNBC).

> TNBC is one of the most aggressive types of cancer in women, characterised by a lack of specific receptors which can be targeted with traditional hormone therapy.

> The benchtop γ-CUBE showed clear and specific accumulation of the radiolabelled antibodies in TROP-2-positive tumours.

Evaluating theranostics for triple-negative breast cancer

In a recent study by Wu et al., the MOLECUBES γ-CUBE for preclinical SPECT imaging was used to image antibodies radiolabelled with 177Lu to evaluate the effectiveness for theranostics in treating triple-negative breast cancer (TNBC). TNBC is one of the most aggressive types of cancer in women, characterised by a lack of specific receptors, such as oestrogen, progesterone, and HER2, which can be targeted with traditional hormone therapy.

The protein Trophoblast cell-surface antigen-2 (TROP-2) is commonly overexpressed in TNBC patients. The radiolabelled antibody developed by Wu et al. allows TROP-2 levels in tumours to be non-invasively quantified to determine future possible treatments.

High-resolution SPECT imaging

The MOLECUBES γ-CUBE showed clear and specific accumulation of the radiolabelled antibodies in TROP-2-positive tumours, showing markedly higher signal than the control groups. Ex vivo biodistribution and histological analysis validated the SPECT imaging results, further supporting the precise localisation of the 177Lu-labelled antibodies. Consequently, high-resolution SPECT imaging allowed Wu et al. to accurately monitor responses and validate the theranostic potential of the 177Lu-radiolabelled antibodies to treat TNBC.

Find out more

You can learn more about MOLECUBES γ-CUBE by clicking the button below to speak to a product specialist directly.

CONTACT US

Case Studies Archive

We use cookies to give you the best possible experience on our web site. Please refer to our Privacy Policy for more information.